Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Great news and Games
View:
Post by beechguy on Aug 28, 2015 3:02pm

Great news and Games

Slough it off as games. Nobody in their right mind would sell at .49 with this news. This will be $2.50 + leading up to February 12th. Play your games and get rid of the weak kneed ones. Kudos to Berendt and Olds. Amazing filing! Graeme... hope you sold all of your shares to fund the kitty rash ointment company. Now with our 45mm in cash lets attack the EU submission and get rolling with Canada HC filings. This quarter I want to see a Nasdaq Tier 2 listing. Note to Endo and Valeant -- sharpen the pencils boys, it's gonna cost you. GLTA beech
Comment by Tson99 on Aug 28, 2015 3:20pm
Agreed...price for partnership just got a lot higher! 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities